TCG Advisors’s Novo Nordisk NVO Stock Holding History

TCG Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,000	Closed	-$26K	–	312
2019 Q2	$26K	Hold	1,000	–	–	0.02%	193
2019 Q1	$27K	Buy	+1,000	New	+$24.6K	0.02%	195

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

TCG Advisors's NVO Position: Q3 2019 in Review

TCG Advisors sold out of Novo Nordisk (NVO) in Q3 2019, closing a stake of 1,000 shares — an estimated $26K sold.

TCG Advisors first reported a position in NVO in Q1 2019 and held it in 2 quarters. The position peaked at $27K in Q1 2019. 564 funds tracked by Wall St. Rank hold NVO as of Q3 2019.

TCG Advisors reported no remaining Novo Nordisk position as of Q3 2019 after selling out during the quarter.
TCG Advisors sold 1,000 Novo Nordisk shares in Q3 2019, an estimated $26K.
TCG Advisors first reported a position in Novo Nordisk in Q1 2019 and held it in 2 quarters.
TCG Advisors's Novo Nordisk position peaked at $27K in Q1 2019.
564 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2019.

Based on TCG Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.